Top 20 Companies in Global Avascular Necrosis Market: Statistics Report Till 2035

Description

According to a research report published by Spherical Insights & Consulting, The Global Avascular Necrosis Market Size Is Projected To Grow From USD 558.32 Million In 2024 To USD 1048.17 Million By 2035, At A CAGR Of 5.89% During The Forecast Period 2024–2035. The global avascular necrosis market is driven by the rising incidence of trauma, corticosteroid use, and alcohol abuse drives avascular necrosis cases. An aging population and orthopedic disorders increase the demand for treatment. Advancements in early diagnostic imaging and regenerative therapies support market growth. Improved healthcare access and awareness further accelerate the adoption of surgical and non-surgical treatment options globally.

 

Introduction

The global avascular necrosis market comprises diagnostic, therapeutic, and surgical solutions addressing osteonecrosis, a condition caused by disrupted blood supply leading to bone tissue death and joint deterioration. The market includes imaging technologies, pharmacological treatments, and surgical interventions such as core decompression and joint replacement. Market growth is driven by the increasing incidence of trauma, corticosteroid use, and alcohol-related disorders. Government-backed clinical observations indicate that corticosteroids account for nearly 27% of avascular necrosis cases, while alcohol contributes around 37%, highlighting key risk factors influencing disease burden. Additionally, rising post-pandemic complications, particularly steroid-induced cases following COVID-19 treatment, have contributed to increased diagnosis rates since 2024. Opportunities are emerging in regenerative medicine, including stem cell therapies and biologics aimed at delaying joint replacement. Increased public healthcare initiatives, improved imaging accessibility, and ongoing government-supported research into bone disorders are further supporting innovation. Recent developments also reflect growing clinical focus on early screening and management to reduce long-term disability.

 

News:

In March 2026, a complex vascularized fibular graft surgery performed at a government medical institute in India demonstrated successful functional recovery in a young AVN patient, showcasing advancements in reconstructive orthopedic procedures.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Avascular Necrosis Market.

 

Market Segmentation

Global Avascular Necrosis Market Size, Share, and, By Type (Traumatic Avascular Necrosis and Non-Traumatic Avascular Necrosis), By Diagnosis (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and Others), By Treatment (Medications, Core Decompression, Bone Grafting, Joint Replacement, and Regenerative Therapy), By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), By Application (Hip, Knee, Shoulder, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa), Analysis and Forecast 2024 – 2035.

 

Global Avascular Necrosis Market Size & Statistics

• The market size for Global Avascular Necrosis was estimated to be worth USD 558.32 Million in 2024.
• The market is going to expand at a CAGR of 5.89% between 2024 and 2035.
• The Global Avascular Necrosis market size is anticipated to reach USD 1048.17 Million by 2035.
• North America is expected to generate the largest revenue during the forecast period in the Global Avascular Necrosis market
• Asia Pacific is expected to grow at the fastest rate during the forecast period in the Global Avascular Necrosis market.

Regional growth and demand                                   

Asia Pacific is expected to grow at the fastest rate during the forecast period in the global avascular necrosis market. Asia Pacific is expected to grow at the fastest rate due to its expanding patient pool, rising incidence of trauma and steroid-induced conditions, and improving healthcare infrastructure. Increasing healthcare expenditure, greater access to diagnostic imaging, and growing awareness are accelerating early diagnosis and treatment adoption. Additionally, the presence of large aging populations in countries such as China and India supports sustained market expansion.

 

North America is expected to generate the largest revenue during the forecast period in the global avascular necrosis market. North America is expected to generate the highest revenue, owing to advanced healthcare systems, high diagnostic rates, and strong adoption of innovative treatment approaches. The region benefits from robust research funding, well-established reimbursement frameworks, and the presence of leading medical device and pharmaceutical companies. The United States, in particular, contributes significantly due to its high healthcare spending and early integration of advanced therapies.

 

 

Top 10 Trends in the Global Avascular Necrosis Market

• Increasing Adoption of Early Diagnostic Imaging
• Rising Focus on Regenerative Medicine and Stem Cell Therapies
• Growth In Minimally Invasive Surgical Procedures
• Advancements In Orthopedic Implant Technologies
• Increasing Prevalence of Steroid-Induced Avascular Necrosis
• Expansion Of Healthcare Infrastructure in Emerging Economies
• Growing Demand for Joint Preservation Techniques
• Integration Of Biologics in Treatment Approaches
• Rising Awareness and Early Screening Initiatives
• Strategic Collaborations and Acquisitions Among Key Players

 

• Increasing Adoption of Early Diagnostic Imaging

The growing use of advanced diagnostic imaging techniques, particularly magnetic resonance imaging, is significantly influencing the avascular necrosis market. Early-stage detection has become more feasible due to improved imaging accuracy, enabling timely clinical intervention before irreversible bone damage occurs. Healthcare providers are increasingly prioritizing early diagnosis to reduce the need for invasive surgical procedures such as joint replacement. Additionally, the expansion of imaging infrastructure in both developed and developing regions is supporting broader access to diagnostic services. This trend is further reinforced by clinical guidelines emphasizing early screening in high-risk populations, ultimately improving patient outcomes and reducing long-term treatment costs globally.

 

• Rising Focus on Regenerative Medicine and Stem Cell Therapies

Regenerative medicine is emerging as a transformative trend in the treatment of avascular necrosis, with increasing research directed toward stem cell-based therapies. These approaches aim to restore blood supply and regenerate damaged bone tissue, addressing the underlying cause of the condition rather than merely managing symptoms. Clinical studies are exploring the efficacy of mesenchymal stem cells in enhancing bone repair and delaying disease progression. Growing investment from both public and private sectors is accelerating innovation in this area. As a result, regenerative therapies are expected to provide long-term treatment alternatives, reducing dependency on joint replacement surgeries and improving patient quality of life significantly.

 

• Growth in Minimally Invasive Surgical Procedures

Minimally invasive surgical techniques are gaining prominence as preferred treatment options for avascular necrosis due to their reduced recovery time and lower complication rates. Procedures such as core decompression are increasingly utilized to relieve intraosseous pressure and improve blood flow to affected bone regions. Technological advancements have enhanced surgical precision, enabling better clinical outcomes with smaller incisions and minimal tissue disruption. Patients are showing greater preference for these procedures as they allow quicker rehabilitation and reduced hospital stays. Furthermore, healthcare systems are encouraging minimally invasive approaches to optimize resource utilization, making them a key trend shaping treatment strategies across global markets.

 

• Advancements in Orthopedic Implant Technologies

Continuous innovation in orthopedic implant technologies is significantly contributing to the evolution of avascular necrosis treatment. Modern implants are designed with improved biocompatibility, durability, and anatomical precision, enhancing surgical outcomes in joint replacement procedures. The adoption of 3D printing and customized implant solutions is enabling better fit and functionality, particularly in complex cases. Additionally, advancements in materials such as highly cross-linked polyethylene and ceramic components are reducing wear and extending implant lifespan. These developments are improving patient mobility and long-term success rates. As a result, advanced implants are becoming integral to managing advanced stages of avascular necrosis effectively.

 

• Increasing Prevalence of Steroid-Induced Avascular Necrosis

The rising prevalence of steroid-induced avascular necrosis is a significant factor influencing market dynamics. Prolonged corticosteroid use, commonly associated with the treatment of chronic inflammatory and autoimmune conditions, has been identified as a major risk factor for the disease. The increased use of steroids during and after global health emergencies has further contributed to a surge in related cases. This trend is driving demand for both early diagnostic solutions and effective treatment options. Healthcare professionals are placing greater emphasis on monitoring high-risk patients, which is leading to increased screening rates and earlier intervention in clinical practice worldwide.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global avascular necrosis market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Global Avascular Necrosis Market.

 

Top 20 Companies Leading the Global Avascular Necrosis Market

1. Stryker Corporation
2. Zimmer Biomet Holdings Inc.
3. Smith & Nephew plc
4. DePuy Synthes
5. B. Braun Melsungen AG
6. MicroPort Scientific Corporation
7. CONMED Corporation
8. Corin Group
9. Medacta International
10. United Orthopedic Corporation
11. Mesoblast Limited
12. Athersys Inc.
13. Vericel Corporation
14. RTI Surgical Holdings
15. Regrow Biosciences Pvt. Ltd.
16. Pfizer Inc.
17. Novartis AG
18. Merck & Co., Inc.
19. Sanofi S.A.
20. Dr. Reddy’s Laboratories Ltd.

 

• Stryker Corporation

Headquarters: Kalamazoo, Michigan, U.S

Stryker Corporation, active in over 75 countries, is a leading global medical technology company specializing in orthopedic implants and surgical solutions. The company plays a significant role in the avascular necrosis market through its advanced hip replacement systems and minimally invasive surgical technologies. Its comprehensive portfolio supports joint preservation and reconstruction procedures across diverse healthcare settings. Stryker’s strong global distribution network and continuous innovation in implant design enhance treatment outcomes. By focusing on precision-driven solutions and surgeon support systems, the company maintains a strong position in addressing complex orthopedic conditions worldwide.

 

• Zimmer Biomet Holdings Inc.

Headquarters: Warsaw, Indiana, U.S

Zimmer Biomet Holdings Inc., active in over 100 countries, is a globally recognized provider of musculoskeletal healthcare solutions. The company is deeply involved in the avascular necrosis market through its extensive range of hip implants and bone preservation technologies. Its product offerings are designed to support both early-stage intervention and advanced joint reconstruction procedures. Zimmer Biomet emphasizes innovation in implant materials and digital surgical tools, improving clinical precision and patient outcomes. With a strong global footprint and established relationships with healthcare providers, the company continues to play a central role in orthopedic treatment advancements worldwide.

 

• Smith & Nephew plc

Headquarters: London, United Kingdom

Smith & Nephew plc, active in over 100 countries, is a prominent medical technology company focusing on orthopedic reconstruction and advanced surgical solutions. The company contributes to the avascular necrosis market through its hip replacement systems and minimally invasive surgical tools. It also offers advanced wound management and sports medicine products, supporting comprehensive patient care. Smith & Nephew’s emphasis on innovation and clinical efficiency enhances surgical outcomes and recovery processes. Its global presence and strong research capabilities enable the company to address evolving orthopedic challenges, reinforcing its position in the global healthcare landscape.

 

• DePuy Synthes

Headquarters: New Brunswick, New Jersey, U.S

DePuy Synthes, a Johnson & Johnson division, active in over 60 countries, is a major contributor to the global avascular necrosis market. The division specializes in orthopedic and trauma solutions, including advanced hip replacement systems and joint reconstruction technologies. It supports both surgical and post-operative care, enabling effective management of bone-related conditions. The company’s strong research and development capabilities drive continuous innovation in implant design and surgical techniques. With a broad global presence and integrated healthcare solutions, Johnson & Johnson plays a vital role in advancing orthopedic treatment standards worldwide.

 

• B. Braun Melsungen AG

Headquarters: Melsungen, Germany

B. Braun Melsungen AG, active in over 60 countries, is a leading medical technology company offering a wide range of healthcare solutions, including orthopedic and surgical products. In the avascular necrosis market, the company provides instruments and systems that support joint replacement and bone treatment procedures. Its focus on integrated healthcare solutions enhances surgical efficiency and patient safety. B. Braun’s global operations and commitment to innovation enable it to address complex clinical needs. By delivering high-quality medical technologies and supporting healthcare providers, the company contributes significantly to improved orthopedic care worldwide.

 

Are you ready to discover more about the global avascular necrosis market?

The report provides an in-depth analysis of the leading companies operating in the global avascular necrosis market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Stryker Corporation

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis 

1. Zimmer Biomet Holdings Inc.
2. Smith & Nephew plc
3. DePuy Synthes
4. B. Braun Melsungen AG
5. MicroPort Scientific Corporation
6. CONMED Corporation
7. Corin Group
8. Medacta International
9. Others.

 

Conclusion

The global avascular necrosis market is steadily evolving, driven by a combination of rising disease prevalence, improved diagnostic capabilities, and continuous advancements in treatment approaches. As highlighted, the market is transitioning from a traditionally surgery-driven model toward more innovative solutions, including regenerative medicine and minimally invasive procedures. Increasing awareness, expanding healthcare infrastructure, and growing adoption of early screening are further strengthening market growth prospects. Regionally, strong dominance from developed markets alongside rapid growth in emerging economies reflects a balanced expansion trajectory. Additionally, the presence of established orthopedic leaders and emerging regenerative therapy players is fostering a competitive and innovation-driven landscape. Moving forward, sustained investments in research, technological advancements, and patient-centric treatment strategies are expected to reshape disease management. Overall, the market presents significant opportunities for stakeholders aiming to capitalize on evolving clinical needs and long-term healthcare demand.

 

Our Reports

https://www.sphericalinsights.com/reports/ethanol-e-fuel-market

https://www.sphericalinsights.com/reports/rem-sleep-behavior-disorder-market

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter